title: Treatment options for residual insomnia in schizophrenia.
authors.affiliation: Center for Neuropsychiatric Schizophrenia Research & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, Copenhagen University Hospital, Glostrup, Denmark. lone.baandrup@regionh.dk
authors.forename: Lone
authors.initials: L
authors.lastname: Baandrup
authors.forename: Poul
authors.initials: P
authors.lastname: Jennum
authors.forename: Henrik
authors.initials: H
authors.lastname: Lublin
authors.forename: Birte
authors.initials: B
authors.lastname: Glenthoj
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002492:Central Nervous System Depressants / Q000627:therapeutic use*; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D008550:Melatonin / Q000627:therapeutic use*; D000068882:Paliperidone Palmitate; D011743:Pyrimidines / Q000627:therapeutic use*; D018967:Risperidone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D007555:Isoxazoles; D011743:Pyrimidines; D008550:Melatonin; D018967:Risperidone; D000068882:Paliperidone Palmitate